clinic portal

"*" indicates required fields

Reach out to us

AIM: The AI-Driven
Endometrial Receptivity Test

Enhancing Patient Outcomes and Clinical Efficiency.

What is AIM

AIM is a non-invasive technology that increases the chance of pregnancy.

It examines ultrasound images to assess the readiness of the endometrium (lining of the uterus) to determine the optimal time for an embryo transfer, resulting in better chances of implantation and pregnancy.

Who it helps

Better outcomes for patients

AIM gives fertility patients a better chance of having a successful embryo transfer/IVF cycle by ensuring implantation happens when the uterus is ready and receptive for an embryo

Improved results and efficiency for clinicians

AIM helps Assisted Reproductive Technologists and Fertility Specialists improve implantation and pregnancy rates, save time, and increase efficiency in treatment protocols.

How it works

AIM provides fertility specialists and technologists with important information about the status of the endometrium, the lining of the uterus. Fertility specialists can then use this information to help determine the best time for an embryo to be implanted into the uterus. The process is simple:

Clinics upload a series of specialized ultrasound images of the endometrium to the AIM portal

Using proprietary algorithms and specialized technologies, AIM generates insights into endometrial receptivity that cannot be detected in routine clinical practice.

AIM provides a research-based numeric endometrial quality score to the clinician.

Accurate identification of low probability cycles.